Transferrin modifications and lipid peroxidation: Implications in diabetes mellitus

Free Radical Research

Volumn 37, Issue 10, 2003, Pages 1069-1077

  Van Campenhout, Ann ^a   Van Campenhout, Christel M ^b   Lagrou, Albert R ^a   Manuel Y Keenoy, Begoña ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Diabetes; Glycation; Iron; Lipid peroxidation; Transferrin

Indexed keywords

ANTIOXIDANT; APOTRANSFERRIN; FREE RADICAL; GLUCOSE; IRON; LIPID; TRANSFERRIN;

ANTIOXIDANT ACTIVITY; CHEMOLUMINESCENCE; CHRONIC DISEASE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE ANALYSIS; HUMAN; LIPID PEROXIDATION; NONPHOTOCHEMICAL QUENCHING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPROTEINS; BRAIN; CATTLE; CHEMILUMINESCENT MEASUREMENTS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; GLUCOSE; HUMANS; IRON; LIPID METABOLISM; LIPID PEROXIDATION; LIPOSOMES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN BINDING; TIME FACTORS; TRANSFERRIN;

EID: 0142062458     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760310001600390     Document Type: Review

References (57)

1. Kannel, W.B. and McGee, D.L. (1979) "Diabetes and glucose tolerance as risk factors for cardiovascular disease: the framingham study" Diabetes Care 2, 120-126.
2. Haffner, S.M., Lehto, S., Ronnemaa, T., Pyorala, K. and Laakso, M. (1998) "Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction" N. Engl. J. Med. 339, 229-234.
3. Mooradian, A.D. (1991) "Increased serum conjugated dienes in elderly diabetic patients", J. Am. Geriatric. Soc. 39, 571-574.
4. Gallou, G., Ruelland, A., Legras, B., Maugendre, D., Allanic, H. and Cloarec, L. (1993) "Plasma malondialdehyde in type 1 and type 2 diabetic patients", Clin. Chim. Acta 214, 227-234.
5. Gallou, G., Ruelland, A., Campion, L., Maugendre, D., Le Moullec, N., Legras, B., Allanic, H. and Cloarec, L. (1994) "Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus", Diabetes Metab. 20, 258-264.
6. Griesmacher, A., Kindhauser, M., Andert, S.E., Schreiner, W., Toma, C., Knoebl, P, Pietschmann, P., Prager, R., Schnack, C., Schernthaner, G. and Mueller, M.M. (1995) "Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus", Am. J. Med. 80, 469-474.
7. Ruiz, C., Alegria, A., Barbera, R., Farre, R. and Lagarda, M.J. (1999) "Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus", Scand. J. Clin. Lab. Investig. 59, 99-105.
8. Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D. and Nicotera, T. (1996) "Oxidative damage to DNA in diabetes mellitus", Lancet 347, 444-445.
9. Baynes, J.W. (1991) "Role of oxidative stress in the development of complications in diabetes", Diabetes 40, 405-412.
10. Laakso, M. (1999) "Hyperglycemia and cardiovascular disease in type 2 diabetes", Diabetes 48, 937-942.
11. Ceriello, A. (1997) "Acute hyperglycemia and oxidative stress generation", Diabetes Med. 14, S45-S49.
12. Wolff, S.P (1993) "Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications", Br. Med. Bull. 49, 642-652.
13. Gutteridge, J.M., Rowley, D.A. and Halliwell, B. (1982) "Superoxide-dependent formation of hydroxyl radical and lipid peroxidation in the presence of iron salt: detection of "catalytic" iron and antioxidant activity in extracellular fluids", Biochem. J. 206, 605-609.
14. Braughler, J.M., Duncan, L.A. and Chase, R.L. (1986) "The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation", J. Biol. Chem. 261, 10282-10289.
15. Herbert, V., Shaw, S., Jayatilleke, E. and Stopler-Kasdan, T. (1994) "Most free radical injury is iron related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine", Stem Cells 12, 289-303.
16. Rice-Evans, C. (1993) "Oxidised low density lipoproteins", In: Poli, G., Albano, E. and Dianzani, M.U., eds, Free Radicals: From Basic Science to Medicine (Birkhäuser Verlag, Basel), pp 323-339.
17. Wolff, S.P. and Dean, R.T. (1987) "Glucose autoxidation and protein oxidation: the role of autoxidative glycosylation in diabetes mellitus and ageing", Biochem. J. 245, 243-250.
18. Wolff, S.P., Crabbe, M.J. and Thornalley, P.J. (1984) "The autoxidation of simple monosaccharides", Experienta 40, 244-246.
19. Hunt, J.V., Bottoms, M.A. and Mitchinson, M.J. (1993) "Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production", Biochem. J. 291, 529-535.
20. Hunt, J.V, Dean, R.T. and Wolff, S.P. (1988) "Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental protein glycation model of diabetes mellitus and ageing", Biochem. J. 256, 205-212.
21. Wolff, S.P., Bascal, Z.A. and Hunt, J.V. (1989) "Autoxidative glycosylation: free radicals and glycation theory", Prog. Clin. Biol. Res. 304, 259-275.
22. Cutler, P. (1989) Deferoxamine therapy in high-ferritin diabetes", Diabetes 38, 1207-1210.
23. Phelps, G., Chapman, I., Hall, P., Braund, W. and MacKinnon, M. (1989) "Prevalence of genetic haemochromatosis among diabetic patients", Lancet 2, 233-234.
24. Tuomainen, T.P., Nyyssönen, K., Salonen, R., Tervahauta, A., Korpela, H., Lakka, T., Kaplan, G.A. and Salonen, J.T. (1997) "Body iron stores are associated with serum insulin and blood glucose concentrations", Diabetes Care 20, 426-428.
25. Ford, E.S. and Gogswell, M.E. (1999) "Diabetes and serum ferritin concentrations among U.S. adults", Diabetes Care 22, 1978-1983.
26. Pérez de Nanclares, G., Castano, L., Gaztambide, S., Bilbao, J.R., Gonzalez, M.L. and Vazquez, J.A. (2000) "Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis", N. Engl. J. Med. 343, 890-891.
27. Eshed, I., Elis, A. and Lishner, M. (2001) "Plasma ferritin and type 2 diabetes mellitus: a critical review", Endocr. Res. 27, 91-97.
28. Fernandez-Real, J.M., Lopez-Bermejo, A. and Ricart, W. (2002) "Cross-talk between iron metabolism and diabetes", Diabetes 51, 2348-2354.
29. Aso, Y., Inukai, T., Tayama, K. and Takemura, Y. (2000) "Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes", Acta Diabetol. 37, 87-92.
30. Furth, A. (1997) "Glycated proteins in diabetes", Br. J. Biomed. Sci. 54, 192-200.
31. Wolff, S.P., Jiang, Z.Y. and Hunt, J.V. (1991) "Protein glycation and oxidative stress in diabetes mellitus and ageing", Free Radic. Biol. Med. 10, 339-352.
32. Gutteridge, J.M. and Quinlan, G.J. (1992) "Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins" Biochim. Biophys. Acta 1159, 248-254.
33. Bradford, M.M. (1976) "A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding", Anal. Biochem. 72, 248-254.
34. Breuer, W. and Cabantchik, I. (2001) "A fluorescence-based one-step assay for serum non-transferrin-bound iron", Anal. Biochem. 299, 194-202.
35. Lissi, E., Salim-Hanna, M., Pascual, C. and del Castillo, M.D. (1995) "Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements", Free Radic. Biol. Med. 18, 153-158.
36. Telci, A., Cakatay, U., Kayali, R., Erdogan, C., Orhan, Y., Sivas, A. and Akcay, T. (2000) "Oxidative protein damage in plasma of type 2 diabetic patients" Horm. Metab. Res. 32, 40-43.
37. Cakatay, U., Telci, A., Salman, S., Satman, L. and Sivas, A. (2000) "Oxidative protein damage in type 1 diabetic patients with and without complications", Endocr. Res. 26, 365-379.
38. Martin, P, Walton, C., Chapman, C., Bodansky, H.J. and Stickland, M.H. (1990) "Increased urinary excretion of transferrin in children with type 1 diabetes mellitus", Diabetes Med. 7, 35-40.
39. O' Donnell, M.J., Martin, P., Florkowski, C.M., Toop, M.J., Chapman, C. and Holder, R. (1991) "Urinary transferrin excretion in type 1 (insulin-dependent) diabetes mellitus", Diabetes Med. 8, 657-661.
40. Cheung, C.K., Cockram, C.S., Yeung, V.T. and Schwaminathan, R. (1989) "Urinary excretion of transferrin in non-insulin dependent diabetics: a marker for early complications?", Clin. Chem. 35, 1672-1674.
41. McCormick, C.P., Konen, J.P. and Shihabi, Z.K. (1990) "Microtransferrinuria and microalbumineria. I. In the diabetic human" Clin. Physiol. Biochem. 8, 53-58.
42. Bernard, A.M., Amor, A.A., Goemaere-Vanneste, J., Antoine, J.L., Lauwerys, R.R., Lambert, A. and Vandeleene, B. (1988) "Microtransferrinuria is a more sensitive marker of early glomerular damage in diabetes than microalbuminuria", Clin. Chem. 34, 1920-1921.
43. Kazumi, T., Hozumi, T., Ishida, Y., Ikeda, Y., Kishi, K., Hayakawa, M. and Yoshino, G. (1999) "Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes", Diabetes Care 22, 1176-1180.
44. De Block, C.E., Van Campenhout, C.M., De Leeuw, I.H., Manuel y Keenoy, B., Martin, M., Van Hoof, V. and Van Gaal, L.F. (2000) "Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes", Diabetes Care 23, 1384-1388.
45. Fujimoto, S., Kawakami, N. and Ohara, A. (1995) "Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production", Biol. Pharm. Bull. 18, 396-400.
46. Mauricio, D., Pérez, A., Riera, A., Arroyo, J.A., de Leiva, A. and Gimferrer, E. (1995) "Serum parameters of iron metabolism in type I (insulin dependent) diabetes mellitus", Diabes. Nutr. Metab. 8, 315-316.
47. Singh, R., Barden, A., Mori, T. and Beilin, L. (2001) "Advanced glycation end-products: a review", Diabetologia 44, 129-146.
48. Bucala, R. and Cerami, A. (1992) "Advanced glycosylation: chemistry, biology, and implications for diabetes and aging", Adv. Pharmacol. 23, 1-34.
49. Brownlee, M., Cerami, A. and Vlassara, H. (1988) "Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications", N. Engl. J. Med. 318, 1315-1321.
50. Brownlee, M., Vlassara, H. and Cerami, A. (1984) "Nonenzymatic glycosylation and the pathogenesis of diabetic complications", Ann. Intern. Med. 101, 527-537.
51. Brieland, J.K. and Fantone, J.C. (1991) "Ferrous iron release from transferrin by human neutrophil-derived superoxide anion: effect of pH and iron saturation", Arch. Biochem. Biophys. 284, 78-83.
52. Kar, M. and Chakraborti, A.S. (1999) "Release of iron from haemoglobin - a possible source of free radicals in diabetes mellitus", Indian J. Exp. Biol. 37, 190-192.
53. Austin, G.E., Mullins, R.H. and Morin, L.G. (1987) "Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients", Clin. Chem. 33, 2220-2224.
54. Kunika, K., Yamaoka, T. and Itakura, M. (1997) "Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria", Diabetes Res. Clin. Pract. 36, 1-9.
55. Schleicher, B.E. and Wieland, O.H. (1989) "Protein glycation: measurement and clinical relevance", J. Clin. Chem. Clin. Biochem. 27, 577-587.
56. 3+", Clin. Chem. 33, 405-407.
57. Hirose, M. (2000) "The structural mechanism for iron uptake and release by transferrins", Biosci. Biotechnol. Biochem. 64, 1328-1336.